SEC 13F Intelligence

Dundas Partners LLP / RME

Dundas Partners LLP’s Resmed Inc Position

Does Dundas Partners LLP own Resmed Inc (RME)? Yes — 203.0K shares worth $46M (+3.63% of its 13F portfolio) as of Q1 2026, down from 205.0K shares the prior filed quarter.

Position Value
$46M
Q1 2026
Shares
203.0K
% of Portfolio
+3.63%
Quarters Held
9
currently held

Position History RME

Reported value by quarter
Q1 ’24: $21,559Q1 ’24Q2 ’24: $25,399Q3 ’24: $34MQ3 ’24Q4 ’24: $32MQ1 ’25: $34MQ1 ’25Q2 ’25: $39MQ3 ’25: $48MQ3 ’25Q4 ’25: $49MQ1 ’26: $46MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026203.0K$46M+3.63%
Q4 2025205.0K$49M+3.48%
Q3 2025175.1K$48M+3.38%
Q2 2025152.2K$39M+2.73%
Q1 2025152.2K$34M+2.51%
Q4 2024140.6K$32M+2.25%
Q3 2024140.6K$34M+2.47%
Q2 2024132.7K$25,399+1.97%
Q1 2024108.9K$21,559+1.70%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Dundas Partners LLP’s full portfolio or all institutional holders of RME.